Displaying results 1 - 25 of 542 for pharmaceuticals. Subscribe to this search
TRENTON, N.J. - Just about every segment of the medical community is piling on the pharmaceutical industry these days, accusing drug makers of deceiving the public, manipulating doctors and putting profits before patients.
PHOENIX - Phoenix will begin testing for trace amounts of pharmaceuticals in its drinking water supply in the wake of an Associated Press investigation that found contamination in many of the nation's major cities.
George Allen’s Alzheimer’s disease left him crying uncontrollably all day and pacing all night. After several medications failed to stop the 74-year-old’s tears or continuous walks, a caregiver at his assisted living home in Mesa found the magic bullet: Zoloft, the nation’s most prescribed antidepressant drug, made by Pfizer Inc.
DRUG SUPPLY THREATENED: Betty Allen visits her husband, George, in his assisted-living home in Mesa.
INSYS Therapeutics, Inc., a specialty pharmaceutical company, has recently signed a lease to move its headquarters to Chandler from Phoenix.
INSYS Therapeutics, Inc., a specialty pharmaceutical company, has recently signed a lease to move its headquarters to Chandler from Phoenix.
A man who told police he committed six armed robberies at drugstores throughout east Mesa because he was addicted to prescription drugs was arrested on suspicion of armed robbery Tuesday after alert Walgreens employees were able to apprehend him outside the store.
Tests for the presence of 14 pharmaceuticals in Scottsdale's municipal water system found only an "infinitesimal" trace of caffeine and no traces of 13 other drugs, the city's Water Quality Department said Thursday.
CVS/Caremark Corp. will eliminate 136 positions at its offices in Scottsdale, less than three months after cutting 423 positions at its Phoenix mail-order operations and less than a year after officials announced plans to hire more workers in the Valley.
West Pharmaceutical Services plans to restructure its Tech Group segment through reductions and consolidation, but its 550 employees in the East Valley will be spared for now.
Modern medicine is truly a wonder of our age, but it is not an unmixed blessing.
Scottsdale-based Medicis’ plans to purchase rival Inamed Corp. are surging forward despite Inamed’s recent surprise setback — a federal panel’s snub for the company’s silicone gel breast implants.
FOUNDER: J.D. Weir, president and CEO of Primus Pharmaceuticals in Scottsdale.
Mesa is urging residents to stop flushing pharmaceuticals down the toilet or pouring them down the drain to prevent chemicals from polluting groundwater.
Dan Froelich of IsXperia sells all natural pharmaceutical grade health and skin care products ranging in price from $20 to $60.
Pharmaceutical company GlaxoSmithKline is experimenting with European-style open offices in Durham, N.C. Robert Nash, who directs the company's environmental health, safety research and development, works at a "floating" desk.
LONDON -- An ugly scramble is brewing over the swine flu vaccine - and when it becomes available, Britain, the United States and other nations could find that the contracts they signed with pharmaceutical companies are easily broken.
WASHINGTON — President Barack Obama on Monday welcomed the pharmaceutical industry's agreement to help close a gap in Medicare's drug coverage, calling the pact a step forward in the push for overhaul of the nation's health care system.
Scottsdale-based Medicis Pharmaceutical Corp. announced a regular quarterly dividend of 3 cents per share Friday.
Earthmovers prepare for construction for the future home of Medicis Pharmaceutical Corporation’s new headquarters being built on the Salt River Pima-Maricopa Community. The project should be complete in 2008.
The Drug Enforcement Administration and its state, local and tribal law enforcement partners will give the public another opportunity to prevent pill abuse and theft by ridding their homes of potentially dangerous expired, unused, and unwanted prescription drugs.
Arizona legislators on Tuesday will review Attorney General Tom Horne’s plan for use of the state’s $6 million share of a multistate settlement with the drug company Johnson & Johnson.
Guest commentary by Phil Kerpen
By Mark Heller, Tribune
By Mark Scarp, contributing columnist
By Jerry Brown, contributing columnist
Guest Commentary by Bill Richardson
© Copyright 2013, East Valley Tribune, Tempe, AZ. [Terms of Use | Privacy Policy]
A Division of 10/13 Communications